Sanofi
Found 8 free book(s)
Myochrysine (sodium aurothiolamate) - Sanofi
products.sanofi.caPRESCRIBING INFORMATION PrMYOCHRYSINE® (sodium aurothiomalate injection, Mfr. Std.) 10, 25 and 50 mg/mL Anti-Rheumatic Agent (disease modifying) sanofi-aventis Canada Inc. Date of Revision:
Décision n° 13-D-11 du 14 mai 2013 relative à des ...
www.autoritedelaconcurrence.frLe rapporteur, le rapporteur général adjoint, le commissaire du ouvernement et les G représentants des sociétés Teva SantéSanofi, -Aventis France, Sanofi SA, Bristol Myers
Renvela (sevelamer carbonate) - Sanofi
products.sanofi.caRenvela (sevelamer carbonate) Product Monograph Page 1 of 21. PRODUCT MONOGRAPH . PrRENVELA®. sevelamer carbonate tablets . 800 mg . Phosphate Binder . ATC code: VO3A EO2
TETRAXIM Sanofi-Pasteur - Modern Medicine
www.meppo.com–if your child suffers from convulsant or non-con-vulsant progressive encephalopathy (neurological disease), –if your child has experienced a strong reaction
Information about t he sanofi-aventis U.S. Patient ...
www.rxresource.orgPATIE NAM ADD CITY DAT DO Y PRO ARE If no SOC WHA (Inclu HOW Patient C Patient N and accur Doctor/He does not g and (3) …
HIGHLIGHTS OF PRESCRIBING INFORMATION …
products.sanofi.usFULL PRESCRIBING INFORMATION WARNING: RISK OF SERIOUS INFECTIONS PatientstreatedwithKEVZARAareatincreasedriskfordevelopingseriousinfectionsthat
SUMMARY OF PRODUCT CHARACTERISTICS 1 …
www.sanofi-aventis.co.ukReference: 67128 2011-10-13 - DSPC - Datapharm SPC 0.1 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Eloxatin 5 mg/ml concentrate for solution for infusion
SUMMARY OF PRODUCT CHARACTERISTICS 1 …
www.sanofi-aventis.co.ukSUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Targocid 200mg Teicoplanin 200mg Powder for Injection Targocid 400mg Teicoplanin 400mg Powder for Injection